These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24173041)

  • 1. Novel immunomodulatory approaches for the management of multiple sclerosis.
    Kantarci OH; Pirko I; Rodriguez M
    Clin Pharmacol Ther; 2014 Jan; 95(1):32-44. PubMed ID: 24173041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New and emerging treatments for multiple sclerosis].
    Louapre C; Maillart É; Papeix C; Lubetzki C
    Med Sci (Paris); 2013 Dec; 29(12):1105-10. PubMed ID: 24356140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic approaches for multiple sclerosis.
    De Jager PL; Hafler DA
    Annu Rev Med; 2007; 58():417-32. PubMed ID: 17217332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis.
    Aktas O; Kieseier B; Hartung HP
    Trends Neurosci; 2010 Mar; 33(3):140-52. PubMed ID: 20045200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: new insights in pathogenesis and novel therapeutics.
    Ontaneda D; Hyland M; Cohen JA
    Annu Rev Med; 2012; 63():389-404. PubMed ID: 21888515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis.
    Banwell B; Tremlett H
    Neurology; 2005 Mar; 64(5):778-9. PubMed ID: 15753408
    [No Abstract]   [Full Text] [Related]  

  • 7. Central nervous system infections - a potential complication of systemic immunotherapy.
    Hemmer B; Frohman E; Hartung HP; Stüve O
    Curr Opin Neurol; 2006 Jun; 19(3):271-6. PubMed ID: 16702834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic aspects of multiple sclerosis.
    Boppana S; Huang H; Ito K; Dhib-Jalbut S
    Mt Sinai J Med; 2011; 78(2):207-20. PubMed ID: 21425265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical approach to immunomodulatory therapy for multiple sclerosis.
    Burks JS
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):449-66, ix. PubMed ID: 15893681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.
    Miller DJ; Rodriguez M
    Microsc Res Tech; 1995 Oct; 32(3):230-45. PubMed ID: 8527857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory drug treatment in multiple sclerosis.
    Aharoni R
    Expert Rev Neurother; 2010 Sep; 10(9):1423-36. PubMed ID: 20819013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current state of research on multiple sclerosis].
    Lubina-Dabrowska N; Stepień A; Chalimoniuk M
    Pol Merkur Lekarski; 2013 Mar; 34(201):135-9. PubMed ID: 23700821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of interferon-beta in the treatment of multiple sclerosis.
    Derwenskus J; Lublin FD
    Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838
    [No Abstract]   [Full Text] [Related]  

  • 14. Linkage between immunomodulation, neuroprotection and neurogenesis.
    Aharoni R; Arnon R
    Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of tobacco smoking on clinical effectiveness of immunomodulatory treatment in multiple sclerosis patients].
    Jernas Ł; Piorunek T; Tokarz E; Wygladalska-Jernas H; Kozubski W; Michalak S
    Przegl Lek; 2012; 69(10):750-2. PubMed ID: 23421025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of multiple sclerosis treatment.
    Cohen JA
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S55-61. PubMed ID: 19200869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drug therapies for multiple sclerosis.
    Mangas A; Coveñas R; Geffard M
    Curr Opin Neurol; 2010 Jun; 23(3):287-92. PubMed ID: 20414110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies.
    Imitola J; Chitnis T; Khoury SJ
    Arch Neurol; 2006 Jan; 63(1):25-33. PubMed ID: 16401734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory treatment strategies in multiple sclerosis.
    Kieseier BC; Wiendl H; Leussink VI; Stüve O
    J Neurol; 2008 Dec; 255 Suppl 6():15-21. PubMed ID: 19300955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B; Hartung HP
    Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.